美女高潮喷水白浆后入在线观看_出a级黑粗大硬长爽猛视频_qvod日韩伦理电影_亚洲自偷自拍三级_成人黄片视频_精品综合无码在线观看_亚洲综合无码中文字幕伊人_亚洲男人天堂最新版_夫洗澡公强我了60分钟_免费看又爽又黄又猛的视频

抗腫瘤壞死因子受體超家族成員10C(TNFRSF10C)多克隆抗體

Anti-Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C) Polyclonal Antibody

CD263; TNFRSF10-C; DCR1; LIT; TRAILR3; TRID; Decoy Receptor 1; Tnf-Related Apoptosis-Inducing Ligand Receptor 3; Trail Receptor Without An Intracellular Domain

  • 抗腫瘤壞死因子受體超家族成員10C(TNFRSF10C)多克隆抗體 產(chǎn)品包裝(模擬)
  • 抗腫瘤壞死因子受體超家族成員10C(TNFRSF10C)多克隆抗體 產(chǎn)品包裝(模擬)
  • 抗腫瘤壞死因子受體超家族成員10C(TNFRSF10C)多克隆抗體 Human peripheral blood lymphocytes were stained with 20μg/ml rabbit Anti-human 42a Polyclonal Antibody (Catalog FAA137Hu01, left) or Isotype control antibody (Catalog IS067-Rb01, right), followed by 1μg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
  • Certificate 通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

用法

For flow cytometry, the suggested use of this reagent is 1-5 μl per 10^6 cells in 100 μl volume.
Optimal working dilutions could be determined by end user.

儲(chǔ)存

經(jīng)常使用則4°C保存。-20°C保存不超過(guò)一年。避免反復(fù)凍融。

贈(zèng)品

相關(guān)產(chǎn)品

編號(hào) 適用物種:Homo sapiens (Human,人) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
URPA137Hu01 腫瘤壞死因子受體超家族成員10C(TNFRSF10C)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UPAA137Hu01 腫瘤壞死因子受體超家族成員10C(TNFRSF10C)多克隆抗體 WB; IHC; ICC; IP.
UFAA137Hu01 抗腫瘤壞死因子受體超家族成員10C(TNFRSF10C)多克隆抗體 FCM
UMAA137Hu23 腫瘤壞死因子受體超家族成員10C(TNFRSF10C)單克隆抗體 WB
UMAA137Hu24 腫瘤壞死因子受體超家族成員10C(TNFRSF10C)單克隆抗體 WB
UMAA137Hu25 腫瘤壞死因子受體超家族成員10C(TNFRSF10C)單克隆抗體 WB
UMAA137Hu26 腫瘤壞死因子受體超家族成員10C(TNFRSF10C)單克隆抗體 WB
UMAA137Hu27 腫瘤壞死因子受體超家族成員10C(TNFRSF10C)單克隆抗體 WB
UMAA137Hu28 腫瘤壞死因子受體超家族成員10C(TNFRSF10C)單克隆抗體 WB
UMAA137Hu29 腫瘤壞死因子受體超家族成員10C(TNFRSF10C)單克隆抗體 WB
UMAA137Hu21 腫瘤壞死因子受體超家族成員10C(TNFRSF10C)單克隆抗體 WB
UMAA137Hu22 腫瘤壞死因子受體超家族成員10C(TNFRSF10C)單克隆抗體 WB
USEA137Hu 腫瘤壞死因子受體超家族成員10C(TNFRSF10C)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
ULMA137Hu 腫瘤壞死因子受體超家族成員10C(TNFRSF10C)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.
留言咨詢